Announcements Trials
Browse Landscape

Status

Recruiting 6Not yet recruiting 2Completed 2Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Neoplasms 14Breast Neoplasms 11Melanoma 10Lung Neoplasms 8Colorectal Neoplasms 8Prostatic Neoplasms 7Neoplasm Metastasis 7Multiple Myeloma 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Lymphoma, Non-Hodgkin 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hodgkin Disease 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Rectal Neoplasms 4Hematologic Neoplasms 4Glioblastoma 4Endometrial Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Lymphoma, T-Cell, Peripheral 3Lymphoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hematopoietic and Lymphatic System Neoplasm × 30 days × Clear all
NCT07082257 2026-05-28

Precision Performance Status Compared With ECOG Performance Status

University of Southern California

Terminated
41 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡